Evidence map›Paper›PMID 33333697›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2020

[Active screening of intestinal carbapenem-resistant Enterobacteriaceae in high-risk patients admitted to the hematology wards and its effect evaluation].

X L Huang, S H Wu, P F Shi, L H Xu, C Chen, Y P Xie, D Q Gao, K Chen, J F Tan, L R Liu and 5 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Rapid detection of carbapenem resistance via MALDI-TOF MS using an innovative broth microgrowth assay.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  2. Impact of XpertFrontiers in cellular and infection microbiology · 2025
    Observational
  3. Article
  4. Epidemiology and outcomes of carbapenem-resistantFrontiers in microbiology · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

X L HuangDepartment of Hematology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
S H WuDepartment of Microbiology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
P F ShiDepartment of Hematology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
L H XuDepartment of Microbiology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
C ChenDepartment of Hematology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
Y P XieDepartment of Hematology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
D Q GaoDepartment of Hematology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
K ChenDepartment of Hematology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
J F TanDepartment of Hematology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
L R LiuDepartment of Hematology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
Y XuDepartment of Hematology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
F YangDepartment of Hematology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
M X YuDepartment of Hematology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
S Y WangDepartment of Hospital Infection Prevention and Control, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
S X QianDepartment of Hematology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang 310006, China.
Hangzhou First People's Hospital · CN

Funding

Hangzhou Medical and Health Plan 2018A05Hangzhou Science and Technology Development Plan 20142013A61Zhejiang Basic Public Welfare Research Project LGF18H260009
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carbapenem-Resistant EnterobacteriaceaeEnterobacteriaceae InfectionsHematologyAnti-Bacterial AgentsCross InfectionHumansAnti-Bacterial AgentsActive screeningCarbapenem-resistant EnterobacteriaceaeEvaluation of effect

Identifiers

PMID33333697
PMCPMC7767815
OpenAlexW3115833611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.